TRAF3 and metabolic dysfunction-associated steatotic liver disease: Either hepatocyte or myeloid cell-specific deletion of TRAF3 protects against HFD-induced NAFLD [2,3,19], which indicates that TRAF3 in either hepatocytes or myeloid cells are essential for the pathogenesis of NAFLD.